SB

Sarika Bawariya

Active Director Director DIN 10389848
DIN 10389848 First appointment Nov 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value •••• Premium profile

About Sarika Bawariya

Data last updated:

Sarika Bawariya is a Director at Aranciyo Healthcare Private Limited (since 2023). Aranciyo Healthcare Private Limited reported revenue of ₹32,893 (FY 2024).

DIN 10389848
Primary Designation Director
First Appointment 10 Nov 2023
Oldest Company Age 2 yrs
Largest company Aranciyo Healthcare Private Limited · ₹32,893 (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aranciyo Healthcare Private Limited U86100MP2023PTC068578
Director10 Nov 20232023₹32,893 (FY 2024)Active

Board colleagues of Sarika Bawariya

NameDINCompanyDesignation
Sujeet Kumar Samadder10389847Aranciyo Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aranciyo Healthcare Private Limited
Premium access

Shareholding and investment profile for Sarika Bawariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sarika Bawariya

Sarika Bawariya currently holds 1 directorship: Aranciyo Healthcare Private Limited (Director, since 10 Nov 2023, revenue ₹32,893 (FY 2024)).

Sarika Bawariya was first appointed on 10 Nov 2023 as Director at Aranciyo Healthcare Private Limited.

The current boards of Sarika Bawariya's companies include Sujeet Kumar Samadder (Aranciyo Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available